William P. Sheridan

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About William P. Sheridan

Biocryst Pharmaceuticals Inc reported in an 8-K filed September 14, 2022 that William P. Sheridan was appointed Chief Development Officer, effective September 15, 2022. The proxy statement of Biocryst Pharmaceuticals Inc reports total compensation of $2,658,421 for William P. Sheridan in fiscal 2022, including a base salary of $549,171. Disclosed compensation is on record for 6 fiscal years.

“Effective September 15, 2022, William P. Sheridan, MBBS, will serve as Chief Development Officer of the Company.”

Biocryst Pharmaceuticals Inc Form 8-K, filed September 14, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Explain William P. Sheridan's disclosed executive compensation over time and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Biocryst Pharmaceuticals Inc (BCRX)
Proxy statement

2022-09-15–2023-04-27

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Biocryst Pharmaceuticals Inc

BCRX

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Biocryst Pharmaceuticals Inc (BCRX)	MBBS Chief Development Officer	$549,171	—	$680,320	$1,194,012	$219,668	$15,250	$2,658,421
2021	Biocryst Pharmaceuticals Inc (BCRX)	MBBS Chief Development Officer	$530,600	$21,224	$400,050	$1,287,761	$238,770	$52,826	$2,531,231
2020	Biocryst Pharmaceuticals Inc (BCRX)	MBBS Chief Development Officer	$515,146	—	—	$1,892,951	$257,573	$14,250	$2,679,920
2019	Biocryst Pharmaceuticals Inc (BCRX)	MBBS Chief Medical Officer	$500,142	—	—	$382,994	$170,048	$14,000	$1,067,183
2018	Biocryst Pharmaceuticals Inc (BCRX)	MBBS Chief Medical Officer	$485,574	—	—	$1,626,760	$208,797	$28,088	$2,349,219
2017	Biocryst Pharmaceuticals Inc (BCRX)	Senior Vice President and Chief Medical Officer	$469,143	$155,618	—	$1,001,288	$141,429	$41,072	$1,808,550

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: Chief Development Officer Biocryst Pharmaceuticals Inc (BCRX)
2022-09-15